A new look at the renin–angiotensin system—Focusing on the vascular system
Tài liệu tham khảo
Abadir, 2011, Angiotensin II type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production, J Interferon Cytokine Res, 31, 471, 10.1089/jir.2010.0043
Achard, 2007, Renin receptor expression in human adipose tissue, Am J Physiol Regul Integr Comp Physiol, 292, 274, 10.1152/ajpregu.00439.2005
Advani, 2009, The (pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney, Hypertension, 54, 261, 10.1161/HYPERTENSIONAHA.109.128645
Agoudemos, 2005, Localization of the renin–angiotensin system components to the skeletal muscle microcirculation, Microcirculation, 12, 627, 10.1080/10739680500301664
Anaka, 2005, The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy, FEBS Lett, 579, 1579, 10.1016/j.febslet.2005.01.068
2011, Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals, J Hypertens, 29, 623, 10.1097/HJH.0b013e328344a7de
Asaad, 1982, Vascular wall renin in spontaneously hypertensive rats: potential relevance to hypertension maintenance and antihypertensive effect of captopril, Hypertension, 4, 487, 10.1161/01.HYP.4.4.487
Axelband, 2009, A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes, Regul Pept, 158, 47, 10.1016/j.regpep.2009.08.004
Bader, 2010, Tissue renin–angiotensin–aldosterone systems: targets for pharmacological therapy, Annu Rev Pharmacol Toxicol, 50, 439, 10.1146/annurev.pharmtox.010909.105610
Bader, 2008, Update on tissue renin–angiotensin systems, J Mol Med, 86, 615, 10.1007/s00109-008-0336-0
Baltatu, 2011, Local renin–angiotensin system and the brain—a continuous quest for knowledge, Peptides, 32, 1083, 10.1016/j.peptides.2011.02.008
Barhoumi, 2011, T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury, Hypertension, 57, 469, 10.1161/HYPERTENSIONAHA.110.162941
Batenburg, 2008, Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 28, 1151, 10.1161/ATVBAHA.108.164210
Boustany, 2004, Activation of the systemic and adipose renin–angiotensin system in rats with diet-induced obesity and hypertension, Am J Physiol Regul Integr Comp Physiol, 287, R943, 10.1152/ajpregu.00265.2004
Brandes, 2007, The fatter the better? Perivascular adipose tissue attenuates vascular contraction through different mechanisms, Br J Pharmacol, 151, 303, 10.1038/sj.bjp.0707229
Bujak-Gizycka, 2010, Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12, J Physiol Pharmacol, 61, 679
Campbell, 1987, Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ, Endocrinology, 121, 1616, 10.1210/endo-121-5-1616
Caprio, 2007, Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis, FASEB J, 21, 2185, 10.1096/fj.06-7970com
Carey, 1992, Expression of alpha-smooth muscle actin in the developing kidney vasculature, Hypertension, 19, II168, 10.1161/01.HYP.19.2_Suppl.II168
Carey, 2003, Newly recognized components of the renin–angiotensin system: potential roles in cardiovascular and renal regulation, Endocr Rev, 24, 261, 10.1210/er.2003-0001
Cassis, 2000, Fat cell metabolism: insulin, fatty acids, and renin, Curr Hypertens Rep, 2, 132, 10.1007/s11906-000-0072-5
Cassis, 1996, Characterization and regulation of angiotensin II receptors in rat adipose tissue. angiotensin receptors in adipose tissue, Adv Exp Med Biol, 396, 39, 10.1007/978-1-4899-1376-0_5
Cruciat, 2010, Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling, Science, 327, 459, 10.1126/science.1179802
Cuadra, 2010, A current view of brain renin–angiotensin system: is the (pro)renin receptor the missing link?, Clin Pharmacol Ther, 125, 27
Cummins, 2009, A new addition to the renin–angiotensin peptide family: proAngiotensin-12 (PA12), Cardiovasc Res, 82, 7, 10.1093/cvr/cvp053
Danser, 2003, Local renin–angiotensin systems: the unanswered questions, Int J Biochem Cell Biol, 35, 759, 10.1016/S1357-2725(02)00178-4
Danser, 2008, The Renin Academy Summit: advancing the understanding of renin science, J Renin Angiotensin Aldosterone Syst, 9, 119, 10.3317/jraas.2008.020
Dantas, 2005, Regulation of ACE2 and ANG-(1-7) in the aorta: new insights into the renin–angiotensin system in the control of vascular function, Am J Physiol Heart Circ Physiol, 289, H980, 10.1152/ajpheart.00476.2005
De Ciuceis, 2005, Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury, Arterioscler Thromb Vasc Biol, 25, 2106, 10.1161/01.ATV.0000181743.28028.57
Deliu, 2011, Intracellular angiotensin II activates rat myometrium, Am J Physiol Cell Physiol
De Mello, 2011, On the local cardiac renin–angiotensin system. Basic and clinical implications, Peptides, 32, 1774, 10.1016/j.peptides.2011.06.018
Dzau, 2002, Pathophysiologic and therapeutic importance of tissue ACE: a consensus report, Cardiovasc Drugs Ther, 16, 149, 10.1023/A:1015709617405
Dzau, 1986, Significance of the vascular renin–angiotensin pathway, Hypertension, 8, 553, 10.1161/01.HYP.8.7.553
Dzau, 1984, Vascular wall renin–angiotensin pathway in control of the circulation: a hypothesis, Am J Med, 77, 31, 10.1016/S0002-9343(84)80035-2
Dzau, 1984, Vascular renin–angiotensin: a possible autocrine or paracrine system in control, J Cardiovasc Pharmacol, 6, S377, 10.1097/00005344-198406002-00012
Dzau, 1993, Vascular renin–angiotensin system and vascular protection, J Cardiovasc Pharmacol, 22, S1
Engeli, 1999, Co-expression of renin–angiotensin system genes in human adipose tissue, J Hypertens, 17, 555, 10.1097/00004872-199917040-00014
Engeli, 2003, The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?, Int J Biochem Cell Biol, 35, 807, 10.1016/S1357-2725(02)00311-4
Eringa, 2007, Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue, Microcirculation, 14, 389, 10.1080/10739680701303584
Esteban, 2009, Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation, PLoS One, 4, e5406, 10.1371/journal.pone.0005406
Fletcher, 2010, The renin–angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature, Prog Retin Eye Res, 29, 284, 10.1016/j.preteyeres.2010.03.003
Ferrario, 2011, ACE2: more of Ang-(1-7) or less Ang II?, Curr Opin Nephrol Hypertens, 20, 1, 10.1097/MNH.0b013e3283406f57
Ferrario, 2010, New physiological concepts of the renin–angiotensin system from the investigation of precursors and products of angiotensin I metabolism, Hypertension, 55, 445, 10.1161/HYPERTENSIONAHA.109.145839
Ferreira, 2007, Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla, Regul Pept, 141, 168, 10.1016/j.regpep.2006.12.031
Galic, 2010, Adipose tissue as an endocrine organ, Mol Cell Endocrinol, 316, 129, 10.1016/j.mce.2009.08.018
Galvez, 2006, Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats, Arterioscler Thromb Vasc Biol, 26, 1297, 10.1161/01.ATV.0000220381.40739.dd
Gálvez-Prieto, 2008, Comparative expression analysis of the renin–angiotensin system components between white and brown perivascular adipose tissue, J Endocrinol, 197, 55, 10.1677/JOE-07-0284
Ganten, 1970, Evidence of renin release or production in splanchnic territory, Nature (London), 226, 551, 10.1038/226551a0
Gao, 2007, Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide, Br J Pharmacol, 151, 323, 10.1038/sj.bjp.0707228
Gao, 2006, Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion, Cardiovasc Res, 71, 363, 10.1016/j.cardiores.2006.03.013
Gao, 2005, Perivascular adipose tissue modulates vascular function in the human internal thoracic artery, J Thorac Cardiovasc Surg, 130, 1130, 10.1016/j.jtcvs.2005.05.028
Gava, 2009, Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells, Nephrol Dial Transplant, 24, 1766, 10.1093/ndt/gfn736
Gomez, 1990, Molecular biology of components of the renin–angiotensin system during development, Pediatr Nephrol, 4, 421, 10.1007/BF00862529
Gould, 1964, The presence of renin activity in blood vessel walls, J Exp Med, 119, 389, 10.1084/jem.119.3.389
Grady, 1991, Expression of AT2 receptors in the developing rat fetus, J Clin Invest, 88, 921, 10.1172/JCI115395
Greenstein, 2009, Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients, Circulation, 119, 1661, 10.1161/CIRCULATIONAHA.108.821181
Griendling, 1993, Molecular biology of the renin–angiotensin system, Circulation, 87, 1816, 10.1161/01.CIR.87.6.1816
Gupte, 2008, ACE2 is expressed in mouse adipocytes and regulated by a high fat diet, Am J Physiol Regul Integr Comp Physiol, 295, R781, 10.1152/ajpregu.00183.2008
Gwathmey, 2009, Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production, Am J Physiol Renal Physiol, 296, F1484, 10.1152/ajprenal.90766.2008
Gwathmey, 2010, Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide, Am J Physiol Renal Physiol, 299, F983, 10.1152/ajprenal.00371.2010
Harrison, 2011, Inflammation, immunity, and hypertension, Hypertension, 57, 132, 10.1161/HYPERTENSIONAHA.110.163576
Haznedaroglu, 2010, Pathobiological aspects of the local bone marrow renin–angiotensin system: a review, J Renin Angiotensin Aldosterone Syst, 11, 205, 10.1177/1470320310379876
Heeneman, 2007, Angiotensin-converting enzyme and vascular remodeling, Circ Res, 101, 441, 10.1161/CIRCRESAHA.107.148338
Higuchi, 2007, Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology, Clin Sci (Lond), 112, 417, 10.1042/CS20060342
Hitom, 2010, Role of (pro)renin receptor in cardiovascular cells from the aspect of signaling, Front Biosci, 2, 246
Horiuchi, 1999, Recent progress in angiotensin II type 2 receptor research in the cardiovascular system, Hypertension, 33, 613, 10.1161/01.HYP.33.2.613
Hsueh, 2011, Renin–angiotensin–aldosterone system in diabetes and hypertension, J Clin Hypertens, 13, 224, 10.1111/j.1751-7176.2011.00449.x
Iacobellis, 2008, Do cardiac and perivascular adipose tissue play a role in atherosclerosis?, Curr Diab Rep, 8, 20, 10.1007/s11892-008-0005-2
Johnston, 1992, Renin–angiotensin system: a dual tissue and hormonal system for cardiovascular control, J Hypertens Suppl, 10, S13
Khayat, 1981, Responses of juxtaglomerular cell suspensions to various stimuli, Hypertension, 3, 157, 10.1161/01.HYP.3.2.157
Kinouchi, 2011, Functional characterization of (pro)renin receptor in association with V-ATPase, Front Biosci, 17, 3216, 10.2741/3907
Knecht, 2010, Distinct effects of intravascular and extravascular angiotensin II on cerebrovascular circulation of newborn pigs, Exp Biol Med (Maywood), 235, 1479, 10.1258/ebm.2010.010149
Koh, 2010, Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction, Atherosclerosis, 209, 307, 10.1016/j.atherosclerosis.2009.09.007
Kumar, 2009, Diversity of pathways for intracellular angiotensin II synthesis, Curr Opin Nephrol Hypertens, 18, 33, 10.1097/MNH.0b013e32831a9e20
Kumar, 2009, The intracellular renin–angiotensin system in the heart, Curr Hypertens Rep, 11, 104, 10.1007/s11906-009-0020-y
Larrue, 1989, Renin–angiotensin system in cultured human arterial smooth muscle cells, J Cardiovasc Pharmacol, 4, S43, 10.1097/00005344-198906144-00010
Lemarié, 2010, The angiotensin II type 2 receptor in cardiovascular disease, J Renin Angiotensin Aldosterone Syst, 11, 19, 10.1177/1470320309347785
Lee, 2011, Mas receptors in modulating relaxation induced by perivascular adipose tissue, Life Sci
Lee, 2009, Endothelium-dependent relaxation factor released by perivascular adipose tissue, J Hypertens, 27, 782, 10.1097/HJH.0b013e328324ed86
Lew, 2003, Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP), J Neurochem, 86, 344, 10.1046/j.1471-4159.2003.01852.x
Li, 2011, Intrarenal transfer of an intracellular fluorescent fusion of angiotensin II selectively in proximal tubules increases blood pressure in rats and mice, Am J Physiol Renal Physiol, 300, F1076, 10.1152/ajprenal.00329.2010
Louis, 2011, Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells, Am J Physiol Heart Circ Physiol
Lu, 2011, Alterations in perivascular adipose tissue structure and function in hypertension, Eur J Pharmacol, 656, 68, 10.1016/j.ejphar.2011.01.023
Lu, 2011, Modulation of vein function by perivascular adipose tissue, Eur J Pharmacol, 657, 111, 10.1016/j.ejphar.2010.12.028
Lu, 2007, Angiotensin II increases adipose angiotensinogen expression, Am J Physiol Endocrinol Metab, 292, E1280, 10.1152/ajpendo.00277.2006
Ludwig, 1998, Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules, J Biol Chem, 273, 10939, 10.1074/jbc.273.18.10939
Malik, 2005, Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus, Hypertension, 45, 264, 10.1161/01.HYP.0000153305.50128.a1
Malinowski, 2008, Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor, Eur J Cardiothorac Surg, 33, 225, 10.1016/j.ejcts.2007.11.007
Mathai, 2011, The role of angiotensin in obesity and metabolic disease, Endocr Metab Immune Disord Drug Targets
Mederos, 2011, AT1 receptors as mechanosensors, Curr Opin Pharmacol, 11, 112, 10.1016/j.coph.2010.11.003
Mehta, 2007, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am J Physiol Cell Physiol, 292, C82, 10.1152/ajpcell.00287.2006
Mogi, 2009, New insights into the regulation of angiotensin receptors, Curr Opin Nephrol Hypertens, 18, 138, 10.1097/MNH.0b013e328324f5fa
Muller, 2011, Immune-related effects in hypertension and target-organ damage, Curr Opin Nephrol Hypertens, 20, 113, 10.1097/MNH.0b013e3283436f88
Nahmod, 2010, Impaired function of dendritic cells deficient in angiotensin II type 1 receptors, J Pharmacol Exp Ther, 334, 854, 10.1124/jpet.109.161760
Naruse, 1982, Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells, Hypertension, 4, 70
Nguyen Dinh Cat, 2011, Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors, Hypertension
Nguyen Dinh Cat, 2011, Cell signaling of angiotensin II on vascular tone: novel mechanisms, Curr Hypertens Rep, 13, 122, 10.1007/s11906-011-0187-x
Nguyen, 2011, Renin and prorenin receptor in hypertension: what's new?, Curr Hypertens Rep, 13, 79, 10.1007/s11906-010-0172-9
Nguyen, 2010, The biology of the (pro)renin receptor, J Am Soc Nephrol, 21, 18, 10.1681/ASN.2009030300
Ocaranza, 2010, Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro, J Hypertens, 28, 1054, 10.1097/HJH.0b013e328335d291
Ohtsu, 2006, Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells, Hypertension, 48, 534, 10.1161/01.HYP.0000237975.90870.eb
Okada, 2010, Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity, Metabolism, 59, 1241, 10.1016/j.metabol.2009.11.016
Okamura, 1986, Vascular renin–angiotensin system in two-kidney, one clip hypertensive rats, Hypertension, 8, 560, 10.1161/01.HYP.8.7.560
Oliver, 1984, Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat, J Clin Invest, 74, 1247, 10.1172/JCI111534
Oppermann, 2010, Atrap deficiency increases arterial blood pressure and plasma volume, J Am Soc Nephrol, 21, 468, 10.1681/ASN.2009060658
örneskog, 2008, Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia, J Cardiovasc Med, 9, 1037, 10.2459/JCM.0b013e32830a48bd
Padia, 2008, Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats, Hypertension, 51, 460, 10.1161/HYPERTENSIONAHA.107.103242
Paul, 2006, Physiology of local renin–angiotensin systems, Physiol Rev, 86, 747, 10.1152/physrev.00036.2005
Paul, 1993, Gene expression of the renin–angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction, J Clin Invest, 91, 2058, 10.1172/JCI116428
Pérez-Díaz, 2011, Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line, Pancreas, 40, 701, 10.1097/MPA.0b013e318215a891
Prosser, 2010, Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system, Peptides, 31, 1540, 10.1016/j.peptides.2010.05.009
Pupilli, 1992, Distribution and content of renin and renin mRNA in remnant kidney of adult rat, Am J Physiol, 263, F731
Rabelo, 2011, ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease, Hypertens Res, 34, 154, 10.1038/hr.2010.235
Raizada, 2007, Intracardiac and intrarenal renin–angiotensin systems: mechanisms of cardiovascular and renal effects, J Investig Med, 55, 341, 10.2310/6650.2007.00020
Re, 1982, Renin synthesis by canine aortic smooth muscle cells in culture, Life Sci, 30, 99, 10.1016/0024-3205(82)90641-5
Re, 2004, Tissue renin–angiotensin systems, Med Clin North Am, 88, 19, 10.1016/S0025-7125(03)00124-X
Rentzsch, 2008, Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function, Hypertension, 52, 967, 10.1161/HYPERTENSIONAHA.108.114322
Reudelhuber, 2011, Deciphering the roles of tissue renin–angiotensin systems in whole animals, Hypertension, 57, 532, 10.1161/HYPERTENSIONAHA.110.167114
Reudelhuber, 2010, Prorenin, renin, and their receptor: moving targets, Hypertension, 55, 1071, 10.1161/HYPERTENSIONAHA.108.120279
Rosenthal, 1984, Investigations of components of the renin–angiotensin system in rat vascular tissue, Hypertension, 6, 383, 10.1161/01.HYP.6.3.383
Sakoda, 2010, Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes, Am J Hypertens, 23, 575, 10.1038/ajh.2009.273
Samani, 1991, Renal and extra-renal levels of renin mRNA in experimental hypertension, Clin Sci (Lond), 80, 339, 10.1042/cs0800339
Sampaio, 2007, Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells, Hypertension, 50, 1093, 10.1161/HYPERTENSIONAHA.106.084848
Sampaio, 2007, Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways, Hypertension, 49, 185, 10.1161/01.HYP.0000251865.35728.2f
Santos, 2008, Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis, Exp Physiol, 93, 519, 10.1113/expphysiol.2008.042002
Santos, 2003, Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas, Proc Natl Acad Sci U S A, 100, 8258, 10.1073/pnas.1432869100
Savoia, 2011, Angiotensin II and the vascular phenotype in hypertension, Expert Rev Mol Med, 13, e11, 10.1017/S1462399411001815
Savoia, 2006, Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase, J Hypertens, 24, 2417, 10.1097/01.hjh.0000251902.85675.7e
Savoia, 2005, Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats, J Hypertens, 23, 1037, 10.1097/01.hjh.0000166845.49850.39
Savoia, 2007, Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients, Hypertension, 49, 341, 10.1161/01.HYP.0000253968.95136.b8
Saye, 1993, Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes, Am J Physiol, 264, C1570, 10.1152/ajpcell.1993.264.6.C1570
Schiffrin, 2000, Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan, Circulation, 101, 1653, 10.1161/01.CIR.101.14.1653
Schiffrin, 2004, From bedside to bench to bedside: role of renin–angiotensin–aldosterone system in remodeling of resistance arteries in hypertension, Am J Physiol Heart Circ Physiol, 287, H435, 10.1152/ajpheart.00262.2004
Schinzari, 2011, Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans, J Hypertens, 29, 1743, 10.1097/HJH.0b013e328349ae0d
Shoback, 1983, Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension, J Clin Invest, 72, 2115, 10.1172/JCI111176
Silva, 2007, Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats, Peptides, 28, 702, 10.1016/j.peptides.2006.10.007
Singh, 2010, Pathogenesis and clinical physiology of hypertension, Cardiol Clin, 28, 545, 10.1016/j.ccl.2010.07.001
Siragy, 2010, Role of the intrarenal renin–angiotensin–aldosterone system in chronic kidney disease, Am J Nephrol, 31, 541, 10.1159/000313363
Sitia, 2010, From endothelial dysfunction to atherosclerosis, Autoimmun Rev, 9, 830, 10.1016/j.autrev.2010.07.016
Soltis, 1991, Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness, Clin Exp Hypertens A, 13, 277, 10.3109/10641969109042063
Sparks, 2011, Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension, Hypertension, 57, 577, 10.1161/HYPERTENSIONAHA.110.165274
Steckelings, 2009, The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets, Fundam Clin Pharmacol, 23, 693, 10.1111/j.1472-8206.2009.00780.x
Stegbauer, 2011, New insights into angiotensin receptor actions: from blood pressure to aging, Curr Opin Nephrol Hypertens, 20, 84, 10.1097/MNH.0b013e3283414d40
Su, 1992, Atrial natriuretic factor and renin synthesized in cultured aortic smooth muscle cells of rats, Chin Med Sci J, 7, 112
Swales, 1993, Vascular RAA system, J Hum Hypertens, 7, S3
Tanaka, 2005, The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy, FEBS Lett, 579, 1579, 10.1016/j.febslet.2005.01.068
Thatcher, 2009, The adipose renin–angiotensin system: role in cardiovascular disease, Mol Cell Endocrinol, 302, 111, 10.1016/j.mce.2009.01.019
Thurston, 1979, Vascular renin-like activity and blood pressure maintenance in the rat, Hypertension, 1, 643, 10.1161/01.HYP.1.6.643
Tigerstedt, 1898, Niere und Kreislauf, Skand Arch Physiol, 8, 223, 10.1111/j.1748-1716.1898.tb00272.x
Torretti, 1982, Sympathetic control of renin release, Annu Rev Pharmacol Toxicol, 22, 167, 10.1146/annurev.pa.22.040182.001123
Touyz, 2005, Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology, Antioxid Redox Signal, 7, 1302, 10.1089/ars.2005.7.1302
Touyz, 2002, Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II, Circ Res, 90, 1205, 10.1161/01.RES.0000020404.01971.2F
Touyz, 2001, Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways, J Hypertens, 19, 1245, 10.1097/00004872-200107000-00009
Touyz, 2001, Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells, J Hypertens, 19, 441, 10.1097/00004872-200103000-00012
Ushio-Fukai, 2009, Vascular signaling through G protein-coupled receptors: new concepts, Curr Opin Nephrol Hypertens, 18, 153, 10.1097/MNH.0b013e3283252efe
Velkoska, 2011, Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy, Clin Sci (Lond), 120, 335, 10.1042/CS20100280
Vicaut, 1994, Local renin–angiotensin system in the microcirculation of spontaneously hypertensive rats, Hypertension, 24, 70, 10.1161/01.HYP.24.1.70
Wang, 2010, Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro, J Cardiovasc Pharmacol Ther, 15, 393, 10.1177/1074248410374458
Viel, 2010, Immune regulation and vascular inflammation in genetic hypertension, Am J Physiol Heart Circ Physiol, 298, H938, 10.1152/ajpheart.00707.2009
Wassmann, 2006, Pathophysiological regulation of the AT1-receptor and implications for vascular disease, J Hypertens, 24, S15, 10.1097/01.hjh.0000220402.53869.72
Weiss, 2010, Vascular wall ACE is not required for atherogenesis in ApoE−/− mice, Atherosclerosis, 209, 352, 10.1016/j.atherosclerosis.2009.09.069
Wilkes, 1991, Plasma angiotensins in anephric humans: evidence for an extrarenal angiotensin system, Cardiovasc Pharmacol, 17, 419, 10.1097/00005344-199103000-00010
Wilkinson-Berka, 2002, Characterisation of a thymic renin–angiotensin system in the transgenic m(Ren-2)27 rat, Mol Cell Endocrinol, 194, 201, 10.1016/S0303-7207(02)00217-4
Wilkinson-Berka, 2011, Prorenin the (pro)renin receptor: recent advances and implications for retinal development and disease, Curr Opin Nephrol Hypertens, 20, 69, 10.1097/MNH.0b013e328341328a
Yang, 2010, Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated, J Hypertens, 28, 487, 10.1097/HJH.0b013e3283343250
Zhuo, 2011, New insights and perspectives on intrarenal renin–angiotensin system: focus on intracrine/intracellular angiotensin II, Peptides, 32, 1551, 10.1016/j.peptides.2011.05.012